Are monoclonal antibodies effective in patients with severe obesity in SARS-CoV-2 infected?

Ucciferri, Claudio; Moffa, Livia; Moffa, Samanta; Vecchiet, Jacopo; Falasca, Katia

Ucciferri, Claudio; Moffa, Livia; Moffa, Samanta; Vecchiet, Jacopo; Falasca, Katia.

Afiliación

Ucciferri C; Department of Medicine and Science of Aging, Clinic of Infectious Diseases, University "G. D'Annunzio", Chieti, Pescara, Italy.
Moffa L; Department of Medicine and Science of Aging, Clinic of Infectious Diseases, University "G. D'Annunzio", Chieti, Pescara, Italy.
Moffa S; Department of Pharmacy, University "G. D'Annunzio", Chieti, Pescara, Italy.
Vecchiet J; Department of Medicine and Science of Aging, Clinic of Infectious Diseases, University "G. D'Annunzio", Chieti, Pescara, Italy.
Falasca K; Department of Medicine and Science of Aging, Clinic of Infectious Diseases, University "G. D'Annunzio", Chieti, Pescara, Italy.

Immun Inflamm Dis ; 11(2): e771, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36840489

Asunto(s)

COVID-19; Obesidad Mórbida; Humanos; SARS-CoV-2; Anticuerpos Monoclonales; Obesidad; Colecalciferol

Palabras clave

COVID-19; monoclonal antibody; obesity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Obesidad Mórbida / COVID-19 Límite: Humans Idioma: En Revista: Immun Inflamm Dis Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google